SCHEMBL23540263

SCHEMBL23540263

CS(=O)(=O)c1nc2cc(C(=O)O)ccc2s1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.65
RAB9A P51151 3/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
CA2 P00918 3/20 0.47
TDP1 Q9NUW8 2/20 0.45
DYRK1A Q13627 1/20 0.44
KDM4E B2RXH2 2/20 0.42
NFKB1 P19838 2/20 0.42
NFKB2 Q00653 2/20 0.42
RELA Q04206 2/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 2/20 0.41
HDAC6 Q9UBN7 5/20 0.40
HDAC3 O15379 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC8 Q9BY41 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11583456 0.98 NPC1 (0.63) NPC1RAB9ASMN1; SMN2CA2TDP1
SCHEMBL19838289 0.88 NFKB1 (0.56) NPC1RAB9ASMN1; SMN2CA2TDP1
SCHEMBL11583452 0.87 NPC1 (0.48) NPC1RAB9ASMN1; SMN2CA2DYRK1A
SCHEMBL23536449 0.84 PIK3CA (0.47) NPC1RAB9ASMN1; SMN2CA2KDM4E
SCHEMBL92033 0.82 NPC1 (0.57) NPC1RAB9ASMN1; SMN2CA2TDP1
SCHEMBL1105986 0.79 NPC1 (1.00) NPC1RAB9ASMN1; SMN2TDP1KDM4E
Hydrochloric Acid SCHEMBL11596610 0.78 RAB9A (0.68) NPC1RAB9ASMN1; SMN2CA2TDP1
SCHEMBL9262651 0.76 DYRK1A (0.50) CA2DYRK1AILKPOLBGFER
SCHEMBL1748164 0.76 SMN1; SMN2 (0.53) NPC1RAB9ASMN1; SMN2CA2HDAC6
Hydrochloric Acid SCHEMBL11147127 0.76 CA2 (0.47) NPC1RAB9ACA2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076520-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2022-10-26 EP disclosed
WO-2021127190-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed